J Cancer 2018; 9(18):3361-3365. doi:10.7150/jca.25554

Research Paper

Impact of prostatic anterior fat pads with lymph node staging in prostate cancer

Wei-Chun Weng1,2,3, Li-Hua Huang1, Chao-Yu Hsu1, Min-Che Tung1, Cheng-Kuang Yang4, Jong-Shiaw Jin5, Yen-Chuan Ou1,✉, Shun-Fa Yang2,6,✉

1. Division of Urology, Department of Surgery, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan
2. Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
3. Department of Nursing, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan
4. Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan
5. Department of Pathology, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan
6. Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan

Abstract

Background: Several reports have revealed the presence of lymph nodes in the prostatic anterior fat pad (PAFP). To date, no study has described the characteristics of Taiwanese patients harboring PAFP lymph nodes with metastatic prostate cancer involvement.

Method: Between December 2006 and May 2015, a total of 849 consecutive patients underwent robot-assisted laparoscopic radical prostatectomy with PAFP dissection. Pathological examination of the dissected PAFP was conducted to assess the presence of lymphoid tissue and prostate cancer involvement.

Results: Of the 849 patients, 76 (9.0%) had 1-3 PAFP lymph nodes. Moreover, 11 (1.3%) of the 76 patients had positive lymph node metastases of prostate cancer in the PAFP; 5 (0.6%) of the 11 patients, who had negative pelvic lymph node involvement, were upstaged because of positive metastases in PAFP lymph nodes. Among the 76 patients having PAFP lymph nodes, metastatic lymph nodes were associated with the clinical T stage, preoperative Gleason score, pathological T stage, and pathological N stage (p < 0.001). Patients with pathological seminal vesicle invasion and a higher surgical Gleason score also exhibited PAFP lymph node metastases (p < 0.005).

Conclusion: Our data show that 9.0% of patients had PAFP lymph nodes and that 1.3% had prostate cancer metastases. Additionally, 0.6% of patients were upstaged because of positive metastases in PAFP lymph nodes. Because of the pathological analysis of the PAFP, a few patients were upstaged. Thus, routine pathological analysis of the PAFP should only be conducted for those with higher preoperative prostate-specific antigen, higher Gleason score, and advanced T stage observations.

Keywords: Lymph nodes, prostatic anterior fat pad, prostate cancer

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Weng WC, Huang LH, Hsu CY, Tung MC, Yang CK, Jin JS, Ou YC, Yang SF. Impact of prostatic anterior fat pads with lymph node staging in prostate cancer. J Cancer 2018; 9(18):3361-3365. doi:10.7150/jca.25554. Available from http://www.jcancer.org/v09p3361.htm